2001
A Sojourn in the synthesis and bioactivity of diindolylalkanes. Chakrabarty, M.; Basak, R.; Harigaya, Y. Heterocycles, 55(12), 2431-2447, 2001.

Synthesis of cis- and trans-5,8-dihydroxy-5,6,7,8-tetrahydro-1,4-naphthoquinone. Arima, S.; Yamada (Konda), Y.; Takeda, K.; Takayanagi, H.; Harigaya, Y. Chemical & Pharmaceutical bulletin, 49(10), 1340-1342, 2001.

Novel synthesis of tetrahydro-2(1H)-quinolones using Diels-Alder reactions of 1-arylsulfonyl-2(1H)-pyridones having an electronwithdrawing group. Fujita, R.; Watanabe, K.; Ikeura, W.; Ohtake, Y.; Hongo, H.; Harigaya, Y.; Matsuzaki, H. Tetrahedron, 57, 8841-8850, 2001.

First total synthesis of Mer-N5075A and a diastereomeric mixture of α and β-MAPI, new HIV-I protease inhibitors from a species of Streptmyces. Konda, Y.; Takahashi, Y.; Arima, S.; Sato, N.; Takeda, K.; Dobash, K.; Baba, M.; Harigaya, Y. Tetrahedron, 57, 4311-4321, 2001.

Electrophilic substitution of indole. Part XIX. Synthesis of 15-(1H-indol-3-yl)-1,11,13-trimethyl-12,14-dioxa-9-azapentacyclo[11.3.1.1.0.0]octadeca-2(10),3,5,7-tetraene from indole and acetylacetone. Banerji, J.; Saha, M.; Dutta, U.; Mukherjee, P.; Chattterjee, A.; Harigaya, Y.; Konda, Y.; Hatano, A. The Journal of the Indian Institute of Science, 81(4), 165-168, 2001.

Determination of Absolute Stereochemistries of Arisugacin F and Territrem B, Novel Acetylcholinesterase. Handa, M.; Sunazuka, T.; Nagai, K.; Kimura, R.; Otoguro, K, Harigaya, Y.; Ōmura, S. Journal of Antibiotics, 54(4), 386-391, 2001.

Convergent synthesis of arisugacin skeletons and their acetylcholinesterase inhibitory activity. Handa, M.; Sunazuka, T.; Nagai, K.; Kimura, R.; Shirahata, T.; Tian, Z-M.; Otoguro, K.; Harigaya, Y.; Ōmura, S. Journal of Antibiotics, 54(4), 382-385, 2001.

Synthesis of Phenanthridones using Diels-Arder reactions of 4-substituted 2(1H)-quinolones acting as dienophiles. Fujita, R.; Watanabe, Y.; Yoshisuji, T.; Matsuzaki, H.; Harigaya, Y.; Hongo, H. Chemical & Pharmaceutical Bulletin, 49(4), 407-412, 2001.

Total synthesis of nafuredin, a selective NADH-fumarate reductase inhibitor. Takano, D.; Nagamitsu, T.; Ui, H.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Kuwajima, I.; Ōmura, S. Organic Letters, 3(15), 2289-2291, 2001.

Absolute configuration of nafuredin, a new specific NADH-fumarate reductase inhibitor. Takano, D.; Nagamitsu, T.; Ui, H.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Kuwajima, I.; Ōmura, S. Tetrahedron Letters, 42(16), 3017-3020, 2001.

Nafuredin, a novel inhibitor of NADH-fumarate reductase, produced by Aspergillus niger FT-0554. Ui, H.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Nagamitsu, T.; Takano, D.; Sunazuka, T.; Namikoshi, M; Ōmura, S. Journal of Antibiotics, 54, 234-238, 2001.

An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Ōmura, S.; Miyadera, H.; Ui, H.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Nagamitsu, T.; Takano, D.; Sunazuka,T.; Harder, A.; Kolbl, H.; Namikoshi, M.; Miyoshi, H.; Sakamoto, K.; Kita, K. Proceedings of the National Academy of Sciences of the United States of America, 98, 60-62, 2001.